Stay one step ahead with Lonza Capsugel at Natural Products Expo West 2026

• The company will demonstrate its local manufacturing capabilities, sustainability credentials, and full suite of concept-to-market services.
• Lonza Capsugel will spotlight its North American-manufacturing capabilities, profiling its Greenwood, South Carolina, and Puebla, Mexico facilities.
• It will also highlight its plant-based capsules that support conscientious consumers, including the recently launched Organicaps™ capsules, and its planet-friendly solutions through its Center of Applied Sustainability.
• The new capsule features high oxygen barrier, non-reactive shell, excellent polymer stability and proven filling performance, ideal for preserving organic formulations

Greenwood, South Carolina, 26 February 2026 – At Natural Products Expo West 2026, booth 4257, attendees can explore how Lonza Capsugel helps brands stay one step ahead in the nutraceutical supplement market. The company will demonstrate how its local manufacturing capabilities, sustainability credentials, and full suite of concept-to-market services support customers at every step of the product development journey.

At its booth, Lonza Capsugel will invite visitors to explore:

• The advantages of North American-manufactured capsules: With unmatched scale, local expertise, and specialized North American manufacturing, Lonza Capsugel can help its customers connect with their consumers faster—without compromising on quality. With 65 years of dependable local supply, the company will spotlight its Greenwood, South Carolina, and Puebla, Mexico facilities at Natural Products Expo West 2026.
• Organic capsule solutions consumers can trust: Lonza Capsugel’s Organicaps™ capsules carry the official United States Department of Agriculture (USDA) organic seal, one of the highest organic certification levels available. They are the only USDA organic certified, 100% plant-based,* immediate release pullulan capsule made in North America.** Featuring a high oxygen barrier, non-reactive shell, and excellent polymer stability, Organicaps™ capsules can help brands appeal to conscientious consumers without compromising on performance.
• Supporting customers with planet-friendly solutions: Aligned with the growing number of consumers seeking for more sustainable nutraceutical supplements,^i,ii Lonza Capsugel will highlight how it can help customers in co-creating products with a lower environmental impact and reduced carbon emissions through its Center of Applied Sustainability. At the event, Lonza Capsugel will showcase the expertise available to support customers in claiming data-backed environmental benefits by offering product carbon footprint reports and best-in-class supply chain assessments.
• Clinically studied joint health and mobility support for healthy aging: Lonza Capsugel’s UC-II® undenatured type II collagen is clinically shown to improve joint flexibility—helping joints feel 10 years younger and increase step-count by a quarter of a mile per day. ^iii,iv,v With a uniquely low dose of just 40 mg/day, UC-II® undenatured type II collagen works across a wide range of in-demand delivery formats, including capsules, gummies, and functional foods and beverages, helping brands tap into the growing healthspan market with diverse solutions.^vi
• Innovation Services that take ideas from concept to market: Whether nutraceutical brands need big picture thinking inspired by the latest consumer insights, unique solutions to complex technical challenges, or scale-up support to bring products to market, Lonza Capsugel’s Innovation Services help transform bold ideas into cutting-edge innovations. Backed by advanced polymer science and capsule technology expertise, these flexible, end-to-end services can be tailored to any and every stage of product development.

Success in the nutraceutical market means staying ahead of the curve. But in an industry that never stands still, that can be easier said than done. As one of the largest capsule, dosage form solution, and health ingredient manufacturers worldwide, Lonza Capsugel has the breadth and depth of expertise to anticipate the needs of the industry and provide proactive solutions.

Visitors can book an appointment here to meet with the expert team from Lonza Capsugel at booth 4257.





*Excluding inorganic processing aids.
**According to market data in 2025.

Lonza Capsugel Contact Details

Anne Holderbach
Director, Strategic Marketing
Tel +33 76 267 9876

For Media Inquiries: media@lonza.com

Disclaimer
Certain matters discussed in this media advisory may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this media advisory.


All trademarks belong to Lonza and are registered in CH, US and/or EU, or belong to their respective third party owners and are used only for informational purposes.

Privacy Policy link

---

ⁱ  FMCG Gurus announces their Top Ten Trends for 2025. October 2024. Available at: https://fmcggurus.com/blog/fmcg-gurus-announces-their-top-ten-trends-for-2025/
ⁱⁱ NielsenIQ (2025) The changing story of sustainability. Available at: https://nielseniq.com/global/en/landing-page/tl-the-changing-story-of-sustainability/
ⁱⁱⁱSchön, C. et al. (2022). UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study. Journal of integrative and complementary medicine, 28(6), 540–548.
^ivSoucie, J. M., et al. (2011). Range of motion measurements: reference values and a database for comparison studies. Haemophilia, 17(3), 500-507.
^v Knaub, K. et al. (2022). UC-II® undenatured type II collagen reduces knee joint discomfort and improves mobility in healthy subjects: a randomized, double-blind, placebo-controlled clinical study. Journal of Clinical Trials, 12(1):1000492.
^viPates, et al. (2023). UC-II® undenatured type II collagen data show retention during functional food and beverage prototype processing. Data Br, 48, 109216.